Ferring and Blackstone Life Sciences Invest Over $570 Million USD in Novel Gene Therapy for Bladder Cancer Patients

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2QPU9zm
via IFTTT